FAS Wealth Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $342K | Buy |
843
+326
| +63% | +$132K | 0.03% | 251 |
|
|
2025
Q1 | $257K | Hold |
517
| – | – | 0.02% | 268 |
|
|
2024
Q4 | $269K | Sell |
517
-112
| -18% | -$58.2K | 0.02% | 267 |
|
|
2024
Q3 | $389K | Sell |
629
-120
| -16% | -$74.3K | 0.03% | 238 |
|
|
2024
Q2 | $414K | Hold |
749
| – | – | 0.04% | 223 |
|
|
2024
Q1 | $435K | Sell |
749
-23
| -3% | -$13.4K | 0.04% | 218 |
|
|
2023
Q4 | $410K | Buy |
772
+24
| +3% | +$12.7K | 0.04% | 216 |
|
|
2023
Q3 | $378K | Buy |
748
+54
| +8% | +$27.3K | 0.04% | 212 |
|
|
2023
Q2 | $362K | Buy |
694
+14
| +2% | +$7.3K | 0.05% | 196 |
|
|
2023
Q1 | $392K | Sell |
680
-7
| -1% | -$4.04K | 0.04% | 213 |
|
|
2022
Q4 | $379K | Buy |
687
+7
| +1% | +$3.86K | 0.04% | 220 |
|
|
2022
Q3 | $345K | Buy |
680
+85
| +14% | +$43.1K | 0.04% | 215 |
|
|
2022
Q2 | $323K | Hold |
595
| – | – | 0.03% | 227 |
|
|
2022
Q1 | $351K | Sell |
595
-30
| -5% | -$17.7K | 0.03% | 215 |
|
|
2021
Q4 | $417K | Buy |
625
+36
| +6% | +$24K | 0.04% | 213 |
|
|
2021
Q3 | $337K | Buy |
589
+77
| +15% | +$44.1K | 0.03% | 222 |
|
|
2021
Q2 | $258K | Hold |
512
| – | – | 0.02% | 247 |
|
|
2021
Q1 | $234K | Buy |
512
+31
| +6% | +$14.2K | 0.02% | 240 |
|
|
2020
Q4 | $224K | Buy |
+481
| New | +$224K | 0.03% | 233 |
|